Editas Medicine, Inc. (NASDAQ:EDIT) will hold its 3Q20 earnings conference call with the financial community on 5th November 2020 at 5:00 PM Eastern Time.
The conference call will be webcast live on Internet at www.editasmedicine.com
Earnings Expectation
Editas Medicine, Inc. is expected to report third quarter earnings results, after market close, on Thursday 5th November 2020. Analysts polled by Thomson Reuters anticipate third quarter loss of $ 0.64 per share from revenue of $ 6.36 million. Looking ahead, the full year loss are expected at $ 2.53 per share on the revenues of $ 27.88 million.
Editas Medicine, Inc. operates as a clinical stage genome editing company. The company focuses on developing transformative genomic medicines to treat a range of serious diseases.
